EMAGLIFLOZIN M 5/500MG

EMAGLIFLOZIN M 5/500MG is a combination diabetes medicine that contains Empagliflozin 5 mg and Metformin Hydrochloride 500 mg. This dual-action therapy helps manage Type 2 Diabetes Mellitus (T2DM) by lowering high blood sugar levels, improving overall glycaemic control, and supporting weight management when used with proper diet and exercise.

Empagliflozin, an SGLT2 inhibitor, works by helping your kidneys remove excess glucose through urine, while Metformin, a biguanide, reduces glucose production in the liver and improves insulin sensitivity. Together, they help reduce the risk of long-term diabetes complications.

✅ Key Benefits:

• Effectively lowers and controls blood sugar levels

• Dual action: blocks glucose reabsorption + reduces glucose production

• May help in weight loss and improve heart health

• Can help reduce the risk of cardiovascular and kidney complications

• Supports better diabetes management with fewer tablets